CD200 is involved in the immunoregulatory mechanism [40–43] and may provide a promising treatment strategy in neuroinflammatory diseases, like stroke, cerebral ischemia, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis [44–49]. Here, CD200 is linked to early-onset autosomal dominant Alzheimer disease.